Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Neuropsychiatrie : Klinik, Diagnostik, Therapie Und Rehabilitation : Organ Der Gesellschaft Osterreichischer Nervenarzte Und Psychiater|October 18, 2018
Differences regarding the five-factor personality model in patients with subjective cognitive decline and mild cognitive impairmentEvelyn Berger-Sieczkowski, Bernadette Gruber, Elisabeth Stögmann, et al.
Clinical Neuropathology|January 20, 2016
Gaucher cells are not associated with α-synuclein neuropathology in infantsEvelyn Berger-Sieczkowski, Mirjam I Lutz, Eduard Auff, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 31, 2015
In vitro and in vivo downregulation of the ATP binding cassette transporter B1 by the HMG-CoA reductase inhibitor simvastatinBihter Atil, Evelyn Berger-Sieczkowski, Johanna Bardy, et al.
Practical Neurology|July 17, 2021
Pulse-synchronous torsional nystagmusIvan Milenkovic, Thomas Sycha, Evelyn Berger-Sieczkowski, et al.
Clinical Medicine (London, England)|February 22, 2022
Reduction of physical activity during the COVID-19 pandemic is related to increased neuropsychiatric symptoms in memory clinic patientsRaphael Wurm, Tandis Parvizi, Sara Silvaeih, et al.
Neurology. Clinical Practice|July 9, 2026
Altered EEG in Creutzfeldt-Jakob Disease: Improving Diagnostic Accuracy Using American Clinical Neurophysiology Society 2021 CriteriaEvelyn Berger-Sieczkowski, Gudrun Zulehner, Sigrid Klotz, et al.
Frontiers in Immunology|October 18, 2021
Ocular Motor Abnormalities in Anti-IgLON5 DiseaseStefan Macher, Ivan Milenkovic, Tobias Zrzavy, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 7, 2025
Assessing family history and approaches for identifying patients with dementia with diagnostically significant genetic findingsTheresa König, Sara Silvaieh, Tandis Parvizi, et al.
Human Genomics|June 17, 2023
Comprehensive genetic screening of early-onset dementia patients in an Austrian cohort-suggesting new disease-contributing genesSara Silvaieh, Theresa König, Raphael Wurm, et al.
European Journal of Clinical Pharmacology|May 10, 2021
A phase I study assessing the safety, tolerability, immunogenicity, and low-density lipoprotein cholesterol-lowering activity of immunotherapeutics targeting PCSK9Markus Zeitlinger, Martin Bauer, Roman Reindl-Schwaighofer, et al.
Pageof 2